Company intelligence / Profile preview

CollaGenex Pharmaceuticals

Newtown, Pennsylvania, United Statesbiospace.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

CollaGenex developed Oracea®, the first FDA-approved systemic therapy for rosacea. Clinical trials showed significant reduction in inflammatory lesions compared to placebo. Other pipeline products included incyclinide for acne/rosacea and COL‑118 for erythema of rosacea[6][7]. The company also marketed Periostat® for periodontitis.

Therapeutic areas
DermatologyInfectious DiseasesNephrology
Modalities
Small moleculeSynthetic glucocorticoid corticosteroid (for Pandel)Combination drug (for Alcortin and Novacort)
Industry
Biotech
02

Drug pipeline

1 asset

doxycycline

Commercial
Indications
Rosacea, Acne
03

Partnerships

Medigene AG – licensing agreement for Oracea marketing rights in EU/certain countries[5]Primus Pharmaceuticals – promotion/cooperation agreements on Alcortin™ and Novacort™ [5]Altana AG/Taisho Pharmaceutical – licensing agreement on Pandel®

Beyond the preview

Go deeper on CollaGenex Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CollaGenex Pharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call